DB107-Retroviral Replicating Vector (RRV)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for DB107-Retroviral Replicating Vector (RRV), covering 2025-05-29 to 2025-05-29. Get the full timeline:
Most recent: Clinical Trial Update: DB107-Retroviral Replicating Vector (RRV) Combined With DB107-Flucytosine (FC) in Patients With Recurrent Glioblastoma or Anaplastic Astrocytoma [Phase 2]